Passed One ChamberFiled Feb 13, 2026
Sponsor: Akilah Weber Pierson (D)
Latest Action
Read second time and amended. Re-referred to Com. on APPR.
Jul 2, 2026
Summary
The bill lets pharmacists replace a prescribed biological drug with a biosimilar or interchangeable product unless the doctor explicitly blocks substitution. It also bars health plans from refusing coverage for a drug that remains medically necessary, while permitting them to require a switch to a lower‑cost equivalent under certain conditions. The goal is to increase access to affordable treatments and improve transparency.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 1094 changes status, plus AI-powered summaries and stage predictions.
Sign up free